GH and Cortisol Responses Following an Acute Session of Respiratory Muscle Endurance Training in Severely Obese Patients

Abstract

It is well established that obese patients are hypo-responsive to classical GH-releasing stimuli, including aerobic exercise. Recently, we have demonstrated that whole body vibration was able to markedly stimulate GH secretion in obese patients, thus suggesting that this refractoriness is not absolute but dependent on the GH-releasing stimulus. Furthermore, we have shown the ability of a respiratory muscle endurance training (RMET) to stimulate GH and cortisol secretion in healthy subjects. The objective of this study was to evaluate the effects of RMET on GH and cortisol responses in severely obese patients. Eight severely obese patients (4 M/4 F, mean age±SEM: 22.8±1.6 years, body mass index, BMI: 39.9±1.1 kg/m²) underwent an incremental progressive RMET protocol of 11 daily sessions, obtained through the use of a specifically designed respiratory device (Spiro Tiger^®). The 12^th session of RMET (15 min duration: 1 min at a respiration rate of 28 acts/min, 5 min at 32 acts/min, 5 min at 34 acts/min, 4 min at 36 acts/min) was associated with blood samplings for determination of GH, cortisol, and lactate (LA) levels. An age- and sex-matched normal-weighted control group (n=7, 4 M/3 F, age: 26.1±3.1 years, BMI: 22.4±0.6 kg/m²) was also recruited. In both normal-weighted subjects and obese patients, GH secretion significantly increased after a 15-min RMET session. Although serum GH levels at 30 min were higher in normal-weighted subjects than in obese patients, there was no statistically significant difference in either GH peaks or net GH areas under the curve between the 2 groups. RMET significantly increased serum cortisol levels in normal-weighted subjects, but was associated to a progressive cortisol decline in obese patients. RMET stimulated LA production, with no significant differences in normal-weighted subjects and in obese patients. A 15-min RMET session was capable to induce a GH response in severely obese patients, which was comparable to that recorded in normal-weighted subjects. A progressive decline in serum cortisol levels occurred in obese patients after RMET, while an opposite pattern (i. e., a significant cortisol increase) was found in normal-weighted subjects. Optimization of long-term RMET protocols could represent a valid strategy to (physiologically) stimulate GH/IGF-I system in those GH hyposecretory states such as obesity.

Key words

respiratory muscle endurance training - GH - cortisol - obesity

• References

• 1 Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991; 72: 51-59
• 2 Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 1995; 80: 3209-3222
• 3 Clasey JL, Weltman A, Weltman JY, Chapman IM, Pezzoli SS, Teates CD, Bouchard C, Thorner MO, Hartman ML. Abdominal visceral fat (AVF) is related to 24-h growth hormone (GH) release in both young and older men and women. 79^th Annual Meeting of The Endocrine Society 1997 107 (Abstract OR 29-3)
• 4 Vahl N, Jørgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol 1997; 272: E1108-E1116
• 5 Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 1984; 311: 1403-1407
• 6 Kelijman M, Frohman LA. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J Clin Endocrinol Metab 1988; 66: 489-494
• 7 Cordido F, Dieguez C, Casanueva FF. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab 1990; 70: 1361-1370
• 8 Tanaka K, Inoue S, Numata K, Okazaki H, Nakamura S, Takamura Y. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity. Metabolism 1990; 39: 892-896
• 9 Cordido F, Peñalva A, Dieguez C, Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 1993; 76: 819-823
• 10 Vahl N, Jørgensen JO, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 1996; 81: 2209-2215
• 11 Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E, Ghigo E. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. Int J Obes Relat Metab Disord 1997; 21: 27-32
• 12 Kanaley JA, Weatherup-Dentes MM, Jaynes EB, Hartman ML. Obesity attenuates the growth hormone response to exercise. J Clin Endocrinol Metab 1999; 84: 3156-3161
• 13 Prange Hansen A. Serum growth hormone response to exercise in non-obese and obese normal subjects. Scand J Clin Lab Invest 1973; 31: 175-178
• 14 Weltman A, Weltman JY, Veldhuis JD, Hartman ML. Body composition, physical exercise, growth hormone and obesity. Eat Weight Disord 2001; 6: 28-37
• 15 Crockford PM, Salmon PA. Hormones and obesity . changes in insulin and growth hormone secretion following surgically induced weight loss. Can Med Assoc J 1970; 103: 147-150
• 16 Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebae NE. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995; 80: 1407-1415
• 17 Machado A, Garcia-Lopez D, Gonzalez-Gallego J, Garatachea N. Whole-body vibration training increases muscle strength and mass in older women: a randomized-controlled trial. Scand J Med Sci Sports 2010; 20: 200-207
• 18 Delecluse C, Roelants M, Verschueren S. Strength increase after whole-body vibration compared with resistance training. Med Sci Sports Exerc 2003; 35: 1033-1041
• 19 Sartorio A, Agosti F, De Col A, Marazzi N, Rastelli F, Chiavaroli S, Lafortuna CL, Cella SG, Rigamonti AE. Growth hormone and lactate responses induced by maximal isometric voluntary contractions and whole-body vibrations in healthy subjects. J Endocrinol Invest 2011; 34: 216-221
• 20 Giunta M, Cardinale M, Agosti F, Patrizi A, Compri E, Rigamonti AE, Sartorio A. GH releasing effects of whole body vibration alone or combined with squatting plus external load in severely obese female subjects. Obes Facts (in press)
• 21 Cardinale M, Leiper J, Erskine J, Milroy M, Bell S. The acute effects of different whole body vibration amplitudes on the endocrine system of young healthy men: a preliminary study. Clin Physiol Funct Imaging 2006; 26: 380-384
• 22 Markov G, Spengler CM, Knöpfli-Lenzin C, Stuessi C, Boutellier U. Respiratory muscle training increases cycling endurance without affecting cardiovascular responses to exercise. Eur J Appl Physiol 2001; 85: 233-239
• 23 Stuessi C, Spengler CM, Knöpfli-Lenzin C, Markov G, Boutellier U. Respiratory muscle endurance training in humans increases cycling endurance without affecting blood gas concentrations. Eur J Appl Physiol 2001; 84: 582-586
• 24 McMahon ME, Boutellier U, Smith RM, Spengler CM. Hyperpnea training attenuates peripheral chemosensitivity and improves cycling endurance. J Exp Biol 2002; 205: 3937-3943
• 25 Holm P, Sattler A, Fregosi RF. Endurance training of respiratory muscles improves cycling performance in fit young cyclists. BMC Physiol 2004; 4: 9
• 26 Sartorio A, Agosti F, Patrizi A, Compri E, Mller EE, Cella SG, Rigamonti AE. Growth hormone response induced by a respiratory muscle endurance training in healthy subjects. Horm Met Res 2012; 44: 319-324
• 27 Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci 2006; 1083: 111-128
• 28 Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999; 23: 260-271
• 29 Sartorio A, Jubeau M, Agosti F, De Col A, Marazzi N, Lafortuna CL, Maffiuletti NA. GH responses to two consecutive bouts of neuromuscular electrical stimulation in healthy adults. Eur J Endocrinol 2008; 158: 311-316
• 30 Sartorio A, Agosti F, Marinone PG, Proietti M, Lafortuna CL. Growth hormone responses to repeated bouts of aerobic exercise with different recovery intervals in cyclists. J Endocrinol Invest 2005; 28: RC11-RC14
• 31 Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf) 2004; 61: 250-255
• 32 Kraemer WJ, Fleck SJ, Dziados JE, Harman EA, Marchitelli LJ, Gordon SE, Mello R, Frykman PN, Koziris LP, Triplett NT. Changes in hormonal concentrations after different heavy-resistance exercise protocols in women. J Appl Physiol 1993; 75: 594-604
• 33 Kuoppasalmi K, Näveri H, Härkönen M, Adlercreutz H. Plasma cortisol, androstenedione, testosterone and luteinizing hormone in running exercise of different intensities. Scand J Clin Lab Invest 1980; 40: 403-409
• 34 Snegovskaya V, Viru A. Elevation of cortisol and growth hormone levels in the course of further improvement of performance capacity in trained rowers. Int J Sports Med 1993; 14: 202-206
• 35 Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993; 77: 341-346
• 36 Al-Damluji S. Adrenergic control of the secretion of anterior pituitary hormones. Baillieres Clin Endocrinol Metab 1993; 7: 355-392
• 37 Al-Damluji S, Perry L, Tomlin S, Bouloux P, Grossman A, Rees LH, Besser GM. Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 1987; 45: 68-76
• 38 Struthers AD, Burrin JM, Brown MJ. Exercise-induced increases in plasma catecholamines and growth hormone are augmented by selective alpha 2-adrenoceptor blockade in man. Neuroendocrinology 1986; 44: 22-28
• 39 Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metabolism 1996; 45: 351-356
• 40 Pasquali R, Vicennati V, Calzoni F, Gnudi U, Gambineri A, Ceroni L, Cortelli P, Menozzi R, Sinisi R, Rio GD. Alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity. Clin Endocrinol (Oxf) 2000; 52: 413-421
• 41 Allolio B, Schulte HM, Deuss U, Kallabis D, Hamel E, Winkelman W. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. Acta Endocrinol (Copenh) 1987; 114: 509-514
• 42 Naber D, Pickar D, Davis GC, Cohen RM, Jimerson DC, Elchisak MA, Defraites EG, Kalin NH, Risch SC, Buchsbaum MS. Naloxone effects on -endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Psychopharmacology (Berl) 1981; 74: 125-128
• 43 Thompson DL, Weltman JY, Rogol AD, Metzger DL, Veldhuis JD, Weltman A. Cholinergic and opioid involvement in release of growth hormone during exercise and recovery. J Appl Physiol 1993; 75: 870-878
• 44 Satta MA, Maussier ML, De Rosa G, Valenza V, Testa A, Saletnich I, Napolitano G, Monaco F. Effects of naloxone on adrenocorticotrophin (ACTH) and cortisol in obese subjects. Horm Metab Res 1992; 24: 44-45
• 45 Wahl P, Zinner C, Achtzehn S, Bloch W, Mester J. Effect of high- and low-intensity exercise and metabolic acidosis on levels of GH, IGF-I, IGFBP-3 and cortisol. Growth Horm IGF Res 2010; 20: 380-385